Business Description
Gilead Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US3755581036
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.09 | |||||
Debt-to-EBITDA | 2.38 | |||||
Interest Coverage | 9.33 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.55 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.3 | |||||
3-Year EBITDA Growth Rate | 36.6 | |||||
3-Year EPS without NRI Growth Rate | 24.5 | |||||
3-Year FCF Growth Rate | -0.3 | |||||
3-Year Book Growth Rate | 8.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 5.38 | |||||
Future 3-5Y Total Revenue Growth Rate | 3 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 21.51 | |||||
9-Day RSI | 23.42 | |||||
14-Day RSI | 26.11 | |||||
6-1 Month Momentum % | -7.76 | |||||
12-1 Month Momentum % | -13.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.43 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.64 | |||||
Days Inventory | 91.74 | |||||
Days Sales Outstanding | 60.89 | |||||
Days Payable | 36.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.56 | |||||
Dividend Payout Ratio | 0.5 | |||||
3-Year Dividend Growth Rate | 3.3 | |||||
Forward Dividend Yield % | 4.65 | |||||
5-Year Yield-on-Cost % | 5.96 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 6.27 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 76.04 | |||||
Operating Margin % | 32.48 | |||||
Net Margin % | 20.89 | |||||
FCF Margin % | 27.37 | |||||
ROE % | 26.09 | |||||
ROA % | 9.08 | |||||
ROIC % | 13.55 | |||||
ROC (Joel Greenblatt) % | 142.48 | |||||
ROCE % | 15.43 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.54 | |||||
Forward PE Ratio | 15.41 | |||||
PE Ratio without NRI | 11 | |||||
Shiller PE Ratio | 9.9 | |||||
Price-to-Owner-Earnings | 18.01 | |||||
PEG Ratio | 2.08 | |||||
PS Ratio | 3.02 | |||||
PB Ratio | 3.57 | |||||
Price-to-Free-Cash-Flow | 11.07 | |||||
Price-to-Operating-Cash-Flow | 10.24 | |||||
EV-to-EBIT | 12.7 | |||||
EV-to-Forward-EBIT | 13.94 | |||||
EV-to-EBITDA | 9.44 | |||||
EV-to-Forward-EBITDA | 10.09 | |||||
EV-to-Revenue | 3.66 | |||||
EV-to-Forward-Revenue | 3.62 | |||||
EV-to-FCF | 13.36 | |||||
Price-to-Projected-FCF | 0.82 | |||||
Price-to-Median-PS-Value | 0.81 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.17 | |||||
Earnings Yield (Greenblatt) % | 7.87 | |||||
FCF Yield % | 9.1 | |||||
Forward Rate of Return (Yacktman) % | 19.67 |